Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy
Clinical trial NCT03712397 · COMPLETED
Trial details
- NCT number
- NCT03712397
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-24
- Primary completion
- 2022-12-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.